Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
3.060
-0.220 (-6.71%)
At close: Mar 3, 2026, 4:00 PM EST
3.060
0.00 (0.00%)
Pre-market: Mar 4, 2026, 4:30 AM EST
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $1.09 billion as of March 4, 2026. Its market cap has decreased by -33.94% in one year.
Market Cap
1.09B
Enterprise Value
1.38B
1-Year Change
-33.94%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since the IPO on November 2, 2010, Evotec SE's market cap has increased from $366.30M to $1.09B, an increase of 197.73%. That is a compound annual growth rate of 7.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 1.18B | 3.59% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | 38.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Perrigo Company | 1.82B |
| Amylyx Pharmaceuticals | 1.67B |
| ANI Pharmaceuticals | 1.54B |
| Collegium Pharmaceutical | 1.32B |
| Alvotech | 1.25B |
| Cronos Group | 1.03B |
| BioAge Labs | 929.83M |
| Amphastar Pharmaceuticals | 917.84M |